Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37

Medical Mycology

Volumn 48, Issue 2, 2010, Pages 263-272

  Pereira, H Anne ^a   Tsyshevskaya Hoover, Irina ^a   Hinsley, Heather ^a   Logan, Sreemathi ^a   Nguyen, Melissa ^a   Nguyen, Thuy Trang ^a   Pohl, Jan ^b,d   Wozniak, Karen ^c   Fidel Jr , Paul L ^c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antibiotic peptides; Candida albicans; CAP37; In vitro fungicidal activity; Innate immunity

Indexed keywords

ANTIFUNGAL AGENT; ASPARAGINYLGLUTAMINYLGLYCYLARGINYLHISTIDYLPHENYLALANYLCYSTEINYL GLYCYLGLYCYLALANYLLEUCYLISOLEUCYLHISTIDYLALANYLARGINYLPHENYLALANYL VALYLMETHIONYLTHREONYLALANYLALANYLSERYLCYSTEINYLPHENYLALANYLGLUTAMINE; AZUROCIDIN; FLUCONAZOLE; HEPARIN BINDING PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; DRUG POTENCY; EUKARYOTE; FUNGICIDAL ACTIVITY; FUNGUS HYPHAE; FUNGUS ISOLATION; KINETICS; KLUYVEROMYCES MARXIANUS; NONHUMAN; PICHIA GUILLIERMONDII; PROTEIN DOMAIN; SACCHAROMYCES CEREVISIAE;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; EUKARYOTA; NEGIBACTERIA; SACCHAROMYCES CEREVISIAE;

EID: 76649127073     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903081976     Document Type: Article

References (54)

1. Flodgaard HE, Ostergaard E, Bayne S, e t al. Covalent structure of two novel neutrophile leucocyte-derived proteins of porcine and human origin. Neutrophile elastase homologues with strong monocyte and fibroblast chemotactic activities. Eur J Biochem 1991; 197: 535-547.
2. Gabay JE, Scott RW, Campanelli D, et al. Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci (USA). 1989; 86: 5610-5614.
3. Shafer WM, Martin LE, Spitznagel JK. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect Immun 1984; 45: 29-35.
4. Shafer WM, Martin LE, Spitznagel JK. Late intraphagosomal hydrogen ion concentration favors the in vitro antimicrobial capacity of a 37-kilodalton cationic granule protein of human neutrophil granulocytes. Infect Immun 1986; 53: 651-655.
5. Spitznagel JK. Antibiotic proteins of human neutrophils. J Clin Invest 1990; 86: 1381-1386.
6. Pereira HA, Shafer WM, Pohl J, Martin LE, Spitznagel JK. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest 1990; 85: 1468-1476.
7. Pereira HA, Ruan X, Kumar P. Activation of microglia: a neuroinflammatory role for CAP37. GLIA 2003; 41: 64-72.
8. Morgan JG, Pereira HA, Sukiennicki T, Spitznagel JK, Larrick JW. Human neutrophil granule cationic protein CAP37 is a specific macrophage chemotaxin that shares homology with inflammatory proteinases. Adv Ex Med Biol 1991; 305: 89-96.
9. Ruan X, Chodosh J, Callegan MC, et al. Corneal expression of the inflammatory mediator CAP37. Invest Ophthalmol Vis Sci 2002; 43: 1414-1421.
10. Lee TD, Gonzalez ML, Kumar P, e t al. CAP37, a novel inflammatory mediator. Its expression in endothelial cells and localization to atherosclerotic lesions. Am J Pathol 2002; 160: 841-848.
11. Lee TD, Gonzalez ML, Kumar P, Grammas P, Pereira HA. CAP37, a neutrophil-derived inflammatory mediator augments leukocyte adhesion to endothelial monolayers. Microvasc Res 2003; 66: 38-48.
12. Gonzalez ML, Ruan X, Kumar P, Grammas P, Pereira HA. Functional modulation of smooth muscle cells by the inflammatory mediator CAP37. Microvasc Res 2004; 67: 168-181.
13. Pereira HA, Erdem I, Pohl J, Spitznagel JK. Synthetic bactericidal peptide based on CAP37: a 37 kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc Natl Acad Sci (USA) 1993; 90: 4733-4737.
14. Brackett DJ, Lerner MR, Lacquement MA, He R, Pereira HA. A synthetic lipopolysaccharide-binding peptide based on the neutrophilderived protein CAP37 prevents endotoxin-induced responses in conscious rats. Infect Immun 1997; 65: 2803-2811.
15. Hubalek F, Edmondson DE, Pohl J. Synthesis and characterization of a collagen model. d O-phosphohydroxylysine-containing peptide. Anal Biochem 2002; 306: 124-134.
16. Pohl J, Pereira HA, Martin NM, Spitznagel JK. Amino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocyte-specific chemotactic glycoprotein structurally similar to neutrophil elastase. FEBS Lett 1990; 272: 200-204.
17. Moroder L. Isoteric replacement of sulfur with other chalcogens in peptides and proteins. J Peptide Science 2005; 11: 187-214.
18. Kadosh D, Johnson AD. Induction of the C andida albicans filamentous growth program by relief of transcriptional repression: a genomewide analysis. Mol Biol 2005; 16: 2903-2912.
19. Vylkova S, Li XS, Berner JC, Edgerton M. Distinct antifungal mechanisms: beta defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides. Antimicrob Agents Chemother 2006; 50: 324-331.
20. Kuhn DM, Mukherjee PK, Clark TA, e t al. Candida parapsilosis. Characteri zation in an outbreak setting. Emerging Infect Dis 2004; 10: 1074-1081.
21. Nguyen MH, Peacock JE, Tanner DC, e t al. Therapeutic approaches in patients with candidemia: evaluation in a multicenter prospective observational study. Arch Intern Med 1995; 155: 2429-2435.
22. Warn PA, Sharp A, Morrissey G, Denning DW. In vivo activity of micafungin in a persistently neutropenic murine model of disseminated infection caused by Candida tropicalis. J Antimicrob Agents Chemother 2002; 50: 1071-1074.
23. Sullivan DJ, Morgan GP, Pinjon E, e t al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369-376.
24. Clark TA, Hajjeh RA. Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 2002; 15: 569-574.
25. Hobson RP. The global epidemiology of invasive C andida infections - is the tide turning?. J Hosp Infect 2003; 55: 159-168.
26. Rapp RP. Changing strategies for the management of invasive fungal infections. Pharmacotherapy 2004; 24: 4S - 28S.
27. Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerging Infect Dis 2004; 10: 14-19.
28. Ganz T, Weiss J. Antimicrobial peptides of phagocytes and epithelial. Semin Hematol 1997; 34: 343-354.
29. Hancock REW. Peptide antibiotics. Lancet 1997; 349: 418-422.
30. Hoover DM, Wu Z, Tucke K, Lu W, Lubkowski J. Antimicrobial characterization of human -defensin 3 derivatives. Antimicrob Agents Chemother 2003; 47: 2804-2809.
31. Selsted ME, Szklarek D, Ganz T, Lehrer RI. Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun 1985; 49: 202-206.
32. Edgerton M, Koshlukova SE, Araujo MWB, et al. Salivary histatin 5 and human neutrophil defensins 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother 2000; 44: 3310-3316.
33. Tsai H, Bobek LA. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azolesensitive and -resistant Candida species. Antimicrob Agents Chemother 1997; 41: 2224-2228.
34. Tsai H, Raj PA, Bobek LA. Candidacidal activity of recombinant human salivary histatin-5 and variants. Infect Immun 1996; 64: 5000-5007.
35. Lupetti A, Paulusma-Annema A, Welling MM, e t al. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob Agents Chemother 2000; 44: 3257-3263.
36. Viejo-Diaz M, Andrés MT, Fierro JF. Different anti- Candida activities of two human lactoferrin-derived peptides, Lfpep and Kaliocin-1. Antimicrob Agents Chemother 2005; 49: 2583-2588.
37. Helmerhorst EJ, Van 'T Hof W, Veerman ECI, Simoons-Smit I, Nieuw Amerongen AV. Synthetic histatin analogues with broad spectrum antimicrobial activity. Biochem J 1997; 326: 39-45.
38. Helmerhorst EJ, Reijnders IM, Van 'T Hof W, et al. Amphotericin B- and Fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agents Chemother 1999; 43: 702-704.
39. Tang Y-Q, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun 2002; 70: 6524-6533.
40. Den Hertog AL, Van Marle J, Van Veen HA, et al. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J 2005; 388: 689-695.
41. Pereira HA, Kumar P, Grammas P. Expression of CAP37, a novel inflammatory mediator in Alzheimer's disease. Neurobiol Aging 1996; 17: 753-759.
42. Pereira HA, Kumar P, Lerner MR, Brackett DJ. Inducible expression of the inflammatory protein CAP37 in the epidermis during wound healing. In: Robinson JW (ed.). Focus on Protein Research. Hauppauge, NY: Nova Biomedical Publications, 2004; 127-144.
43. Nizet V, Ohtake T, Lauth X, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414: 454-457.
44. Oren A, Ganz T, Liu L, Meerloo T. In human epidermis, beta defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 2003; 74: 180-182.
45. Shirafuji Y, Oono T, Kanzaki H, Hirakawa S, Arata J. Detection of cryptdin in mouse skin. Clin Diagn Lab Immunol 1999; 6: 336-340.
46. Sørensen OE, Cowland JB, Theilgaard-Mönch K, e t al. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003; 170: 5583-5589.
47. Fellermann K, Stange EF. Defensins - innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol 2001; 13: 771-776.
48. Frohm-Nilsson M, Sandstedt B, Sørensen O, e t al. M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 1999; 67: 2561-2566.
49. Dale BA. Periodontal epithelium: a newly recognized role in health and disease. Periodontal 2003; 30: 70-78.
50. Dale BA, Krisanaprakornkit S., Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med 2000; 30: 321-327.
51. Diamond G, Legarda D, Ryan LK. The innate immune response of the respiratory epithelium. Immunol Rev 2000; 173: 27-38.
52. Hiemstra PS. Epithelial antimicrobial peptides and proteins: their role in host defense and inflammation. Pediatr Respir Rev 2001; 2: 306-310.
53. Huttner KM, Bevins CL. Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 1999; 45: 785-794.
54. Malm J, Sørensen O, Persson T, et al. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations and is attached to spermatozoa. Infect Immun 2000; 68: 4297-4302.